Clinical Trial Update: Cholinergic Neurotransmission in Mobility and Cognition in Parkinson Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update on cholinergic neurotransmission related to mobility and cognition in Parkinson disease and Parkinson disease dementia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinson Disease Dementia

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Parkinson Disease, Parkinson Disease Dementia | Phase 4 | Status: COMPLETED